Evaluation of Liver Fibrosis through Noninvasive Tests in Steatotic Liver Disease
Liver fibrosis, a critical predictor of the prognosis of metabolic dysfunction-associated steatotic liver disease (MASLD), is traditionally diagnosed via biopsy. Nevertheless, non-invasive alternatives, such as serum biomarkers, vibration-controlled transient elastography, and magnetic resonance ela...
Saved in:
Main Author: | Yuri Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
Jin Publishing & Printing Co.
2024-11-01
|
Series: | The Korean Journal of Gastroenterology |
Subjects: | |
Online Access: | https://www.kjg.or.kr/journal/view.html?uid=6061&vmd=Full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Noninvasive Imaging Test to Assess Liver Fibrosis: Vibration-controlled Transient Elastography
by: Mi Na Kim
Published: (2024-11-01) -
Treatment of HCV infection in patients with steatotic liver disease
by: Robert Flisiak, et al.
Published: (2024-07-01) -
Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
by: Yu-Ming Cheng, et al.
Published: (2024-12-01) -
Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
by: K. L. Raikhelson, et al.
Published: (2024-05-01) -
Prevalence and risk factors of liver fibrosis in patients with metabolic-associated fatty liver disease undergoing bariatric surgery
by: Amr Elsayed, et al.
Published: (2024-12-01)